Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-19-010490
Date:2019-09-17
Issuer: KINIKSA PHARMACEUTICALS, LTD. (KNSA)
Original Submission Date:

Reporting Person:

MAHONEY STEPHEN F.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE, 2 CHURCH STREET HAMILTON, D0 HM11

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SHARE OPTION 8.83 2019-09-17 deemed execution date A 82,000 (a) 2029-09-16 class a common shares 82,000 $8.83 82,000 direct
Footnotes
IDfootnote
f1 the option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. the vesting commencement date is september 17, 2019.
WhaleWisdom Logo

Elevate your investments